The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.
Brian Michael Alexander
No relevant relationships to disclose
Patrick Y. Wen
Research Funding - AstraZeneca; Genentech
Eudocia Quant Lee
Consultant or Advisory Role - Genentech; Novartis
Tracy Batchelor
Consultant or Advisory Role - Amgen; Genentech; Merck; Millennium; Roche; Spectrum Pharmaceuticals
Research Funding - Millennium; Pfizer
Timothy Francis Cloughesy
Consultant or Advisory Role - Agios; Amgen; Genentech; Lilly; Novartis; Roche
Honoraria - Merck
Giovanni Parmigiani
No relevant relationships to disclose
Lorenzo Trippa
No relevant relationships to disclose